This accredited learning module explores how to initiate injectable therapy in a patient with type 2 diabetes who remains above their glycaemic target despite taking dual or triple oral therapy. The activity works through 3 in-depth case-studies: a patient with uncomplicated T2D, a patient with ASCVD risk, and a patient with established ASCVD.
This module aims to improve GP confidence in managing early schizophrenia, including identifying and managing negative symptoms to reduce disability for their patients.
Epilepsy is a common problem for older adults, and has a greater impact in older people compared to younger populations. This module describes key differences between the causes and presentation of epilepsy in older versus younger people, as well as special considerations for prescribing antiseizure drugs for older people. This two-hour activity contains a online learning module as well as a patient review exercise involving preparation of a GP Management Plan for a patient.
From 1 October 2021, Australians will require a prescription to legally access e-cigarettes containing nicotine (e-cigarettes), liquid nicotine, and other novel nicotine delivery products, such as heat-not-burn tobacco products. Read about the Therapeutic Goods Administration’s decision about e-cigarettes and what this means for prescribers.
Review practical recommendations from Australian diabetes experts on when and how to use IDegAsp (insulin degludec/insulin aspart) in real-world practice.
This series of podcasts aims to provide general practitioners (GPs) and other healthcare professionals with the latest clinically relevant information and opinions from experts in T2DM about the appropriate management of patients with T2DM in primary care, particularly regarding insulin therapy.
Strong steps in osteoporosis: Learning a step-wise approach to identifying and preventing osteoporotic fracture
This module takes participants though a step-wise model which helps identify patients at risk of osteoporotic fracture, and looks at strategies for prevention and ongoing management.
This education module focuses on a case study of an uncomplicated patient with type 2 diabetes, and the process of intensifying to first injectable therapy. Expert video commentary throughout the module helps step the participant through the decision cycle from the ADA/EASD consensus guidelines for T2D. This module also includes Australian recommendations for patients fasting during Ramadan.